The effect of treatment with pimobendan in dogs with preclinical mitral valve disease – a placebo-controlled double-blinded crossover study

BACKGROUND: Pimobendan is a widely used medication for the treatment of dogs with congestive heart failure (CHF) and preclinical degenerative mitral valve disease (DMVD) with cardiomegaly. The benefit of a treatment in dogs with preclinical DMVD but without cardiomegaly has not yet been elucidated....

Descripción completa

Detalles Bibliográficos
Autores principales: Klein, Stephanie, Nolte, Ingo, Rumstedt, Katja, Sehn, Maximiliane, Raue, Jonathan Friedemann, Weiner, Franziska, Treese, Julia Sophie, Beyerbach, Martin, Bach, Jan-Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467240/
https://www.ncbi.nlm.nih.gov/pubmed/34563187
http://dx.doi.org/10.1186/s12917-021-03014-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467240/
https://www.ncbi.nlm.nih.gov/pubmed/34563187
http://dx.doi.org/10.1186/s12917-021-03014-5

Ejemplares similares